The universal PFAS restriction: the state of play on April 3, 2026

On March 26, 2026, the Socio-Economic Analysis Committee (SEAC) of the European Chemicals Agency (ECHA) published its draft opinion on the so-called universal restriction of PFAS, the per- and polyfluoroalkyl substances, and opened a 60-day consultation. Three weeks earlier, on March 2, the Risk Assessment Committee (RAC) had adopted its own opinion. The two committees agree that a broad restriction is needed. They disagree on nearly everything else, and that disagreement is precisely what tells a manufacturer what can already be decided.

One point of method before the substance: this article describes the procedure as it stands on April 3, 2026, and nothing beyond that date. We will revise it once SEAC adopts its final opinion, expected before the end of the year.

Three years of dossier, two opinions, one consultation open until May 25

The proposal was submitted on January 13, 2023 by five national authorities, Denmark, Germany, the Netherlands, Norway, and Sweden, and published by ECHA on February 7, 2023. It covers more than 10,000 substances through a structural definition rather than a list: a PFAS is any substance carrying at least one fully fluorinated methyl (CF3) or methylene (CF2) carbon. It is the broadest restriction ever proposed under REACH, the European regulation on the registration, evaluation, authorization, and restriction of chemicals.

The 2023 consultation drew more than 5,600 contributions, which the committees then worked through sector by sector for two years. In August 2025, the five authorities published an update of their dossier. To the two original options, a full ban (RO1) and a ban with time-limited derogations (RO2), it added a third route (RO3) that would allow certain uses to continue, fluoropolymers first among them, under strictly controlled conditions: site-specific management plans, updated annually and available for inspection.

Where that leaves the calendar: RAC's opinion adopted on March 2, 2026; SEAC's draft published on March 26, in consultation until May 25; SEAC's final opinion expected by the end of 2026; then the combined opinion goes to the European Commission, which drafts a regulation put to the member states in the REACH Committee and then to scrutiny by the Parliament and the Council. The Commission's decision is expected in 2027. With the general transition period of 18 months, the first bans would take effect in 2029 at the earliest.

The principle is settled. The fight is over the map of derogations

RAC, which owns the risk side, concludes that a full ban is the safest option. Its opinion puts figures on the choice: a 96% reduction in emissions for a total ban, against 76% for the derogation-based option. It rejects a general derogation for so-called degradable PFAS, fluoropolymers included, and clearly endorses only one derogation, for workers' personal protective equipment, with reporting and labeling obligations attached.

SEAC, which owns the socio-economic side, lands almost at the opposite end: a broad restriction is necessary, but a total ban would probably be disproportionate. It favors time-limited derogations, use by use, granted where the evidence exists. It considers the derogation for invasive medical devices justified, for instance, but rejects the open-ended exemption requested for active pharmaceutical ingredients. And it concedes a point industry had been making since 2023: several sectors, among them printing, sealing, some textiles, and certain military uses, were never fully evaluated. For those it proposes an interim generic derogation, pending a proper assessment.

The durations at stake are those of the dossier: an 18-month general transition, then derogations of 5 or 12 years, so 6.5 or 13.5 years in total for the uses that would qualify.

What is already knowable, whichever way the arbitration goes

PFAS are bought for their chemical inertness, and that same inertness is what has earned the entire group its restriction procedure. Three points have held fixed through every version of the dossier since 2023.

The scope. The structural definition is not contested by anyone in the procedure. Fluoropolymers, PTFE included, are inside it; the disagreement between RAC and SEAC concerns the regime they would be given, never their presence in scope. A supplier telling you a PTFE-coated part is "PFAS-free" is using a different definition from the one being legislated.

The paperwork. Every exit route runs on evidence. RO3 requires annual site-specific management plans. SEAC grants derogations only against data on substitution, emissions, and socio-economic impact. The consultation itself accepts only substantiated, quantified arguments. In every scenario published since 2023, the first concrete obligation is the same: knowing where your PFAS are, part number by part number, use by use.

The direction. France did not wait for Brussels. Its law of February 27, 2025 has banned cosmetics, ski wax, and most clothing containing PFAS since January 1, 2026. The European regulation will land later, but the direction of travel is set.

Starting the inventory now, in practice

Waiting for the final text is also a decision. It amounts to betting that the 18-month transition will be enough to locate, across your supplier base, substances most suppliers cannot name. I have read both opinions, and none of the scenarios they open changes the first step.

1. Scope by component family, not by substance. Seals and gaskets, coatings and surface treatments, electronics, technical textiles, fluids and lubricants, food-contact packaging. That is where PFAS live in an industrial bill of materials.
2. Ask suppliers with the definition and a threshold attached. A bare "do you use PFAS?" collects sincere and wrong "no" answers, because most suppliers do not count fluoropolymers.
3. Sort each use into three boxes: alternative available, alternative in development, no known alternative. That is SEAC's own grid, and speaking it is how your data becomes usable later, whether for substitution or for a derogation file.
4. If you hold solid socio-economic data on a use with no alternative, the consultation is open until May 25, 2026. Anonymous contributions are not accepted, and unquantified arguments carry little weight.
5. Put a watch on two dates: SEAC's final opinion by the end of 2026, and the Commission's decision expected in 2027.

Good to know: even a use headed for a derogation will have to be documented, through management plans, reporting, or labeling depending on the option retained. The file that proves your derogation is the same file that prepares your substitution.

Between now and May 25, decide whether you contribute to the consultation. Between now and the end of the year, build the inventory of your at-risk component families, with each supplier answer dated and sourced. And note this article's date: when SEAC adopts its final opinion, we will update it, and you will be able to lay your inventory against the definitive map of derogations.

FAQ

Are fluoropolymers such as PTFE covered by the universal PFAS restriction?

Yes. The proposal defines PFAS structurally, as any substance with at least one fully fluorinated methyl or methylene carbon, which includes fluoropolymers such as PTFE. As of April 2026, neither RAC nor SEAC proposes excluding them from scope; the debate concerns whether their manufacture and use could continue under controlled conditions or time-limited derogations.

When would the universal PFAS restriction take effect?

As of April 2026, SEAC's final opinion is expected by the end of 2026 and the European Commission's decision in 2027. The proposal includes an 18-month general transition period after entry into force, so the first bans would apply in 2029 at the earliest, with derogations of 5 or 12 years for qualifying uses.

Should a mid-sized manufacturer respond to the SEAC consultation?

Only with quantified evidence. The consultation on SEAC's draft opinion runs until May 25, 2026 and accepts substantiated input on alternatives, costs, timelines, and emissions for specific uses. Anonymous contributions are not accepted, and general statements of concern carry little weight.